Katrina’s Blog™
News and Commentary
on the science and technology of drugs and medical devices, including discovery, development, manufacturing, and regulation.
Is Your Startup a Good Fit for SBIR/STTR Funding?
In 2024, life science startups continue to face challenges in accessing equity funding, particularly at the pre-seed/seed stage. Many turn to SBIR/STTR grants as a vital funding option. These grants provide crucial funding and additional benefits, such as honing...
Hidden Barriers: The Language of Business and Diversity
Language is not just a tool for communication in business and entrepreneurship; it's a powerful force that shapes perceptions, decisions, and outcomes. The prevalence of masculine language in business discourse, however, creates a subtle yet significant barrier for...
Female Founder Challenges in the EU
My first article this month reviewed some facts about female founders. I’m not the only one commenting on the challenges they face. xdeck, a European platform to help founders with revolutionary ideas, thought this subject needed more scrutiny. They interviewed 15 of...
Measuring Female Founders – An Update
In the ever-evolving entrepreneurship landscape, female founders continue to make significant strides despite persistent challenges. This article delves into the progress and obstacles women face in the startup ecosystem, drawing from various sources to provide an...
Making a New Medicine Part 4: What Happens After Approval?
The discovery and development of a new medicine is a complex and lengthy process. Many founders begin their search for a new therapy without understanding these details. In my experience, most of the public views drug development as “the news reports that scientists...